Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy.
about
The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunitiescis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment.Cisplatin/carboplatin cross-resistance in ovarian cancerCisplatin-incorporated polymeric micelles eliminate nephrotoxicity, while maintaining antitumor activity.
P2860
Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Treatment of advanced ovarian ...... with intensive prior therapy.
@en
type
label
Treatment of advanced ovarian ...... with intensive prior therapy.
@en
prefLabel
Treatment of advanced ovarian ...... with intensive prior therapy.
@en
P2093
P1476
Treatment of advanced ovarian ...... with intensive prior therapy.
@en
P2093
Bruckner HW
Greenspan EM
Gusberg SB
Holland JF
Wallach RC
P304
P577
1978-04-01T00:00:00Z